| Quarter | Score |
|---|---|
| 2024-Q3 | 87.3 |
| 2024-Q4 | 87.4 |
| 2025-Q1 | 87.2 |
| 2025-Q2 | 87.2 |
| 2025-Q3 | 87.3 |
| 2025-Q4 | 87.4 |
| 2026-Q1 | 87.3 |
| 2026-Q2 | 87.4 |
Strong consensus, but price is extended — wait for pullback to funds' basis
Trading +26.3% above funds' purchase price — elevated pullback risk
5 of 18 tracked funds hold META. Avg conviction: 4.8%. Net adding. First tracked at $588.14 (current +26.3% vs tracked).
Pershing Square has 9.2% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Pershing Square | 9.2% | Add |
| ValueAct Capital | 9.2% | Hold |
| Appaloosa Management | 4.9% | Add |
| Miller Value Partners | 0.9% |
| New Buy |
| Citadel Advisors | 0.1% | Reduce |